Results 1-8 of 8 for drugs segment:8820625

Joint Oireachtas Committee on Health: Health Needs of Persons with Dementia and the Services Available: Discussion (7 Feb 2024)

Gino Kenny: Treatment has been evolving in recent decades. What is at the cutting edge of non-invasive treatment or drugs? Is there any bespoke treatment that Dr. O'Philbin would suggest for dementia care?

Joint Oireachtas Committee on Health: Health Needs of Persons with Dementia and the Services Available: Discussion (7 Feb 2024)

Dr. Laura O'Philbin: When the Deputy says “medical advances”, does he mean drug treatments and pharmacological advances? Is that his question?

Joint Oireachtas Committee on Health: Health Needs of Persons with Dementia and the Services Available: Discussion (7 Feb 2024)

...Agency and we expect a decision on that in a matter of months as to whether it will be approved in Europe. I need to stress to everyone that these treatments are exciting and they are first-generation drugs. The hope is that we can build on them and have a suite of options for people in the future. However, they are not cures and they are only suitable for a small number of people....

Joint Oireachtas Committee on Health: Health Needs of Persons with Dementia and the Services Available: Discussion (7 Feb 2024)

Bernard Durkan: What steps are being taken, if any, to increase the level of support that might be available by way of new age drugs and so on? Testing drugs at European level and at our own level as well is a slow process. We tend very often to test drugs all over again with resultant delays. Why that exists, I do not know. What can and should be done now in the short term to, as it were, help...

Joint Oireachtas Committee on Health: Health Needs of Persons with Dementia and the Services Available: Discussion (7 Feb 2024)

Dr. Laura O'Philbin: In my experience, for the many people who are invested in dementia-specific drugs, such as Dementia Trials Ireland, which was funded in 2021 and is aiming to triple the number of clinical trials available to people living with dementia, it is more the system that slows things down. Obviously, they cannot bring a drug to market or test drugs on people that might not be...

Joint Oireachtas Committee on Health: Health Needs of Persons with Dementia and the Services Available: Discussion (7 Feb 2024)

...what are they getting dressed for? What are they then doing? It is really important that we have the two things happening in parallel: the focus on investment, learning and readying ourselves for the drug therapies that we hope will come, while we still improve services and supports for everyone impacted by dementia.

Joint Oireachtas Committee on Health: Health Needs of Persons with Dementia and the Services Available: Discussion (7 Feb 2024)

Martin Conway: ...that existed in the past that do not exist any more because of the advancement of medicines. Certainly medicines are important. What kind of a timeline are we looking at? These two key drugs have not yet been approved by the European Medicines Agency. Obviously there is a delay on our side for looking at orphan drugs. There is also a question on research. Is there any research...

Joint Oireachtas Committee on Health: Health Needs of Persons with Dementia and the Services Available: Discussion (7 Feb 2024)

...22 trials on topics such as sensory support in nursing homes that looks at people in nursing homes to see if they need hearing aids or visual aids. Another trial looks at neurostimulation and repurposing drugs on agitation. There is a lot happening in Ireland, which is brilliant.